Schonfeld Strategic Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Sell
231,155
-31,701
-12% -$1.74M 0.09% 240
2025
Q1
$18.6M Buy
262,856
+251,756
+2,268% +$17.8M 0.11% 160
2024
Q4
$730K Sell
11,100
-19,548
-64% -$1.28M ﹤0.01% 1196
2024
Q3
$2.15M Sell
30,648
-173,784
-85% -$12.2M 0.01% 728
2024
Q2
$16.8M Buy
204,432
+21,940
+12% +$1.81M 0.11% 177
2024
Q1
$15.9M Buy
182,492
+11,332
+7% +$990K 0.11% 208
2023
Q4
$16.5M Buy
171,160
+76,159
+80% +$7.34M 0.11% 182
2023
Q3
$8.41M Buy
95,001
+36,574
+63% +$3.24M 0.07% 346
2023
Q2
$5.06M Buy
58,427
+45,540
+353% +$3.95M 0.04% 482
2023
Q1
$1.25M Sell
12,887
-57,400
-82% -$5.58M 0.01% 854
2022
Q4
$7.27M Sell
70,287
-26,569
-27% -$2.75M 0.06% 377
2022
Q3
$8.21M Buy
96,856
+94,063
+3,368% +$7.97M 0.07% 373
2022
Q2
$231K Sell
2,793
-35,407
-93% -$2.93M ﹤0.01% 1732
2022
Q1
$2.95M Buy
+38,200
New +$2.95M 0.03% 557
2021
Q4
Sell
-29,300
Closed -$2.27M 1986
2021
Q3
$2.27M Buy
+29,300
New +$2.27M 0.02% 619
2021
Q1
Sell
-18,541
Closed -$1.63M 1756
2020
Q4
$1.63M Buy
18,541
+13,788
+290% +$1.21M 0.02% 627
2020
Q3
$362K Sell
4,753
-4,735
-50% -$361K 0.01% 984
2020
Q2
$1.17M Buy
9,488
+3,138
+49% +$387K 0.03% 530
2020
Q1
$537K Buy
+6,350
New +$537K 0.03% 557
2019
Q4
Sell
-44,700
Closed -$3.01M 1268
2019
Q3
$3.01M Buy
44,700
+37,000
+481% +$2.49M 0.09% 237
2019
Q2
$660K Buy
+7,700
New +$660K 0.02% 562
2018
Q4
Sell
-16,900
Closed -$1.64M 1059
2018
Q3
$1.64M Sell
16,900
-68,900
-80% -$6.68M 0.07% 327
2018
Q2
$8.08M Buy
+85,800
New +$8.08M 0.44% 50
2017
Q3
Sell
-8,093
Closed -$735K 580
2017
Q2
$735K Buy
+8,093
New +$735K 0.08% 328
2017
Q1
Sell
-6,434
Closed -$533K 599
2016
Q4
$533K Buy
+6,434
New +$533K 0.07% 329
2016
Q3
Sell
-38,607
Closed -$3M 420
2016
Q2
$3M Buy
+38,607
New +$3M 0.67% 28